Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28
Original SEC Filing: Click here

---

Webplus: SVA/20090928/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
Sinovac’s H1N1 Vaccine Passes Experts Evaluation Organized by SFDA BEIJING, Aug. 31 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac’s H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license within this week. On

---

---

Webplus: SVA/20090928/6-K/1/000.htm SEC Original: sinovac6k083109.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085